This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (141)  • Contact me when this article is cited  Related Content  • Related letter  • Related article  • Similar articles in JAMA  Topic Collections  • Drug Therapy, Other  • Alert me on articles by topic

Maurizio de Martino, MD; Pier-Angelo Tovo, MD; Maria Balducci, DMath; Luisa Galli, MD; Clara Gabiano, MD; Giovanni Rezza, MD; Patrizio Pezzotti, DStat; for the Italian Register for HIV Infection in Children and the Italian National AIDS Registry

JAMA. 2000;284:190-197.

Context  Since the introduction of combined antiretroviral therapy, mortality rates in adults with human immunodeficiency virus type 1 (HIV-1) infection have decreased. However, little information is available outside the setting of controlled trials on survival of perinatally HIV-infected children treated with antiretroviral therapy.

Objective  To assess effect of availability of antiretroviral therapy on decreasing mortality in perinatally HIV-infected children.

Design  Population-based, multicenter longitudinal study involving data collected by the Italian Register for HIV Infection in Children.

Setting  A network of 106 pediatric clinical centers.

Subjects  A total of 1142 children born between November 1980 and December 1997 with perinatally acquired HIV infection with a median follow-up of 5.9 years.

Main Outcome Measure  Time to HIV-related death calculated for birth cohort and calendar period and grouped by distribution of predominant type of antiretroviral therapy administered over time.

Results  Survival was longer in the 1996-1997 birth cohort (crude relative hazard [RH] of death, 0.39; 95% confidence interval [CI], 0.15-0.96) and 1996-1998 calendar period (crude RH of death, 0.65; 95% CI, 0.45-0.95) than in birth cohort and calendar period 1980-1995, but not when adjusted for maternal antiretroviral treatment during pregnancy and clinical condition at time of delivery, gestational age, and birth weight (adjusted RH of death, 0.55; 95% CI, 0.20-1.50, for birth cohort; and adjusted RH of death, 0.71, 95% CI, 0.43-1.16, for calendar period). In a multivariate model with 1980-1995 as comparison, the 1996-1997 birth cohort had an RH of 0.57 (95% CI, 0.22-1.47; P=.27) but RH for calendar period 1996-1998 was 0.63 (95% CI, 0.47-0.85; P<.01). When the effects of birth cohort, calendar period, and type of antiretroviral therapy were evaluated simultaneously in the same model, the RH of death was not significantly different from 1.0 for the 1996-1997 birth cohort (P=.19) and calendar period 1996-1998 (P=.83) suggesting a causal relationship between decreased risk of death and use of combination therapy. The RH of death in children receiving monotherapy or double or triple combination therapy was 0.77 (95% CI, 0.55-1.08), 0.70 (95% CI, 0.42-1.17), and 0.29 (95% CI, 0.13-0.67), respectively, vs no antiretroviral therapy.

Conclusion  Survival of perinatally HIV-infected children improved in 1996-1998 as a result of the introduction of combined antiretroviral therapies.

Author Affiliations: Department of Pediatrics, University of Florence, Florence (Drs de Martino and Galli); Department of Pediatrics, University of Turin, Turin (Drs Tovo and Gabiano); and Centro Operativo AIDS, Istituto Superiore di Sanità, Rome (Drs Balducci, Rezza, and Pezzotti); Italy.

RELATED LETTER

Antiretroviral Therapy and Mortality Among Children With Perinatal HIV Infection
Jean-Paul Teglas, Marie-Jeanne Mayaux, Stéphane Blanche, Patrizio Pezzotti, Giovanni Rezza, Maria Balducci, Pier-Angelo Tovo, Clara Gabiano, Luisa Galli, and Maurizio de Martino
JAMA. 2000;284(22):2871-2872.
EXTRACT | FULL TEXT  

RELATED ARTICLE

July 12, 2000
JAMA. 2000;284(2):249-250.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Mortality among HIV-1- and Human Herpesvirus Type 8-Affected Mother-Infant Pairs in Zambia
Wojcicki et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:2238-2243.
ABSTRACT | FULL TEXT  

The Role of Cognitive Functioning in Medication Adherence of Children and Adolescents with HIV Infection
Malee et al.
J Pediatr Psychol 2008;0:jsn068v1-jsn068.
ABSTRACT | FULL TEXT  

Quality of Life Among HIV-Infected Children in Thailand
Oberdorfer et al.
J Int Assoc Physicians AIDS Care (Chic Ill) 2008;7:141-147.
ABSTRACT  

Effectiveness of Highly Active Antiretroviral Therapy in HIV-Positive Children: Evaluation at 12 Months in a Routine Program in Cambodia
Janssens et al.
Pediatrics 2007;120:e1134-e1140.
ABSTRACT | FULL TEXT  

Efficacy of Highly Active Antiretroviral Therapy in HIV-1 Infected Children in Kenya
Song et al.
Pediatrics 2007;120:e856-e861.
ABSTRACT | FULL TEXT  

Trends in Hospitalizations of HIV-Infected Children and Adolescents in the United States: Analysis of Data From the 1994 2003 Nationwide Inpatient Sample
Kourtis et al.
Pediatrics 2007;120:e236-e243.
ABSTRACT | FULL TEXT  

Adherence to Antiretroviral Therapy for Pediatric HIV Infection: A Qualitative Systematic Review With Recommendations for Research and Clinical Management
Simoni et al.
Pediatrics 2007;119:e1371-e1383.
ABSTRACT | FULL TEXT  

Short-term mortality and implementation of antiretroviral treatment for critically ill HIV-infected children in a developing country
Cowburn et al.
Arch. Dis. Child. 2007;92:234-241.
ABSTRACT | FULL TEXT  

Cancer Rates After Year 2000 Significantly Decrease in Children With Perinatal HIV Infection: A Study by the Italian Register for HIV Infection in Children
Chiappini et al.
JCO 2007;25:97-101.
ABSTRACT | FULL TEXT  

National Estimates of Hospital Use by Children With HIV Infection in the United States: Analysis of Data From the 2000 KIDS Inpatient Database
Kourtis et al.
Pediatrics 2006;118:e167-e173.
ABSTRACT | FULL TEXT  

Lopinavir/ritonavir exposure in treatment-naive HIV-infected children following twice or once daily administration
Rosso et al.
J Antimicrob Chemother 2006;57:1168-1171.
ABSTRACT | FULL TEXT  

Underdosing of antiretrovirals in UK and Irish children with HIV as an example of problems in prescribing medicines to children, 1997-2005: cohort study.
Menson et al.
BMJ 2006;332:1183-1187.
ABSTRACT | FULL TEXT  

Early Triple Therapy vs Mono or Dual Therapy for Children With Perinatal HIV Infection
Chiappini et al.
JAMA 2006;295:626-628.
FULL TEXT  

The First 5 Years of the Family Clinic for HIV at Tygerberg Hospital: Family Demographics, Survival of Children and Early Impact of Antiretroviral Therapy
van Kooten Niekerk et al.
J Trop Pediatr 2006;52:3-11.
ABSTRACT | FULL TEXT  

Coercive Treatment of HIV-Positive Children Is Not Justified: In Reply
Darville et al.
Pediatrics 2005;116:1606-1608.
FULL TEXT  

The Economic Burden of Home Care for Children with HIV and Other Chronic Illnesses
Wilson et al.
Am. J. Public Health 2005;95:1445-1452.
ABSTRACT | FULL TEXT  

Temporal Trends in Early Clinical Manifestations of Perinatal HIV Infection in a Population-Based Cohort
Berk et al.
JAMA 2005;293:2221-2231.
ABSTRACT | FULL TEXT  

Neuropsychological Functioning and Viral Load in Stable Antiretroviral Therapy-Experienced HIV-Infected Children
Jeremy et al.
Pediatrics 2005;115:380-387.
ABSTRACT | FULL TEXT  

Protease Inhibitor Combination Therapy, Severity of Illness, and Quality of Life Among Children With Perinatally Acquired HIV-1 Infection
Storm et al.
Pediatrics 2005;115:e173-e182.
ABSTRACT | FULL TEXT  

Integrating Adherence to Highly Active Antiretroviral Therapy Into Children's Daily Lives: A Qualitative Study
Hammami et al.
Pediatrics 2004;114:e591-e597.
ABSTRACT | FULL TEXT  

Nonadherence With Pediatric Human Immunodeficiency Virus Therapy as Medical Neglect
Roberts et al.
Pediatrics 2004;114:e346-e353.
ABSTRACT | FULL TEXT  

Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and Ireland
Gibb et al.
BMJ 2003;327:1019.
ABSTRACT | FULL TEXT  

Changes in indinavir exposure over time: a case study in six HIV-1-infected children
Fraaij et al.
J Antimicrob Chemother 2003;52:727-730.
ABSTRACT | FULL TEXT  

Simian Immunodeficiency Virus Infection in Neonatal Macaques
Veazey et al.
J. Virol. 2003;77:8783-8792.
ABSTRACT | FULL TEXT  

The Reliability of Reports of Medical Adherence From Children With HIV and Their Adult Caregivers
Dolezal et al.
J Pediatr Psychol 2003;28:355-361.
ABSTRACT | FULL TEXT  

Determinants of Mother-to-Infant Human Immunodeficiency Virus 1 Transmission Before and After the Introduction of Zidovudine Prophylaxis
The Italian Register for Human Immunodeficiency Vi
Arch Pediatr Adolesc Med 2002;156:915-921.
ABSTRACT | FULL TEXT  

HIV disease and respiratory infection in children
Graham and Gibb
Br Med Bull 2002;61:133-150.
ABSTRACT | FULL TEXT  

Pharmacokinetics of Stavudine and Didanosine Coadministered with Nelfinavir in Human Immunodeficiency Virus-Exposed Neonates
Rongkavilit et al.
Antimicrob. Agents Chemother. 2001;45:3585-3590.
ABSTRACT | FULL TEXT  

Effect of Combination Therapy Including Protease Inhibitors on Mortality among Children and Adolescents Infected with HIV-1
Gortmaker et al.
NEJM 2001;345:1522-1528.
ABSTRACT | FULL TEXT  

Impact of Protease Inhibitor-Containing Combination Antiretroviral Therapies on Height and Weight Growth in HIV-Infected Children
Buchacz et al.
Pediatrics 2001;108:e72-72.
ABSTRACT | FULL TEXT  

Fluctuations in Symptoms in Human Immunodeficiency Virus-Infected Children: The First 10 Years of Life
The European Collaborative Study
Pediatrics 2001;108:116-122.
ABSTRACT | FULL TEXT  

Antiretroviral Therapy and Mortality Among Children With Perinatal HIV Infection
Teglas et al.
JAMA 2000;284:2871-2872.
FULL TEXT  

Combination Antiretroviral Therapy Reduces Pediatric HIV Mortality
JWatch Infect. Diseases 2000;2000:2-2.
FULL TEXT